Each percentage point increase in THC concentration in German cannabis was associated with a significant increase in cannabis-related psychiatric diagnoses, with a stronger effect in men.
Policymakers considering THC potency regulations, public health officials, and harm reduction advocates.
Each 1% THC increase: +0.42 diagnosis increase in men, +0.17 in women
What the researchers found
Using health insurance data from 2009-2021 and THC data from law enforcement, each one percentage point increase in median THC concentration predicted a higher proportion of cannabis users receiving an F12 diagnosis. The effect was stronger in men (+0.42) than women (+0.17).
Why it matters
As cannabis products get stronger worldwide, this population-level data suggests rising potency may translate directly into more psychiatric diagnoses.
The numbers in context
Each 1 percentage point increase in THC associated with +0.42 increase in diagnosis proportion for men and +0.17 for women. Effect significant in all 16 states for men, 15/16 for women.
How the study worked
Ecological study using generalized mixed linear models across 16 German federal states from 2009-2021. Dependent variable was the ratio of insured persons with cannabis-related ICD-10 F12 diagnoses to estimated cannabis users.
What this study cannot tell us
Ecological study design means individual-level causation cannot be established. THC data from seizures may not represent actual consumer use. Changes in diagnostic practices could confound results.
How to read the evidence
Large-scale population data across 16 states and 12 years is compelling, but ecological design introduces uncertainty.
When this study was published
Published in 2024 with data from 2009-2021.
The bigger picture
Several countries and states are considering THC potency caps in legal markets. This German data provides population-level support for the idea that higher potency products carry additional health risks.
Questions still open
- Would THC potency caps in legal markets reduce the rate of cannabis-related diagnoses?
- Why do men appear more susceptible to the potency-diagnosis relationship than women?
Common questions
Does stronger cannabis cause more mental health problems?
Are men more affected by high-potency cannabis?
Read the original research
Can the THC concentration predict the number of patients with cannabis-related diagnoses?
Drug and alcohol review, 43(7), 1764-1772
Citation
Manthey, Jakob; Rosenkranz, Moritz; Jonas, Benjamin; Schwarzkopf, Larissa. (2024). Can the THC concentration predict the number of patients with cannabis-related diagnoses?. Drug and alcohol review, 43(7), 1764-1772. https://doi.org/10.1111/dar.13923
Explore the wider topic
- THC Purity and Potency: What the Label Actually Means
- Dab and Concentrate Withdrawal: Why It Hits Harder
- Delta-8 THC: Addiction, Withdrawal, and What We Don't Know
- Edible Addiction and Withdrawal: What Makes It Different
- Edibles and Psychosis: When a Bad Trip Becomes an Emergency
- Vaping vs Smoking vs Edibles: A Harm Reduction Guide
- How Cannabis Products Are Made: From Plant to Concentrate to Edible
- Laced Weed and Contaminated Vapes: Real Risks vs Myths
- Legal vs Street Weed: Quality, Safety, and What You're Actually Smoking
- Quitting Weed Pens and Dabs: Why Concentrates Hit Different
- Quitting Edibles: Is Withdrawal Different from Smoking?
- Sativa vs Indica: The Myth and the Science Behind Cannabis Strain Labels
- Why Is Weed Withdrawal Worse Now Than 20 Years Ago?